Genetic variation in rates of antipyrine metabolite formation: A study in uninduced twins

M. B. Penno, B. H. Dvorchik, E. S. Vesell

Research output: Contribution to journalArticle

Abstract

Adult, male, unmedicated twins received anti-pyrine orally under carefully controlled environmental conditions. Relative contributions of genetic and environmental factors to 2-fold interindividual variations in rate constants for formation of the three main antipyrine metabolites were compared. Heritabilities for rate constants for formation of 4-hydroxyantipyrine, N-demethylantipyrine, and 3-hydroxymethylantipyrine were 0.88, 0.85, and 0.70, respectively. These results suggest that each molecular form of cytochrome P-450 that converts antipyrine to a different metabolite exhibits genetically controlled interindividual variations in activity. Unrelated adult male subjects whose environments were also carefully controlled exhibited highly reproducible rate constants for formation of antipyrine metabolites. Because the rate constant for metabolite formation sensitively detects certain variations in the gene product, it should be used in future pharmacogenetic studies on rates of production of multiple metabolites from a single parent drug.

Original languageEnglish (US)
Pages (from-to)5193-5196
Number of pages4
JournalProceedings of the National Academy of Sciences of the United States of America
Volume78
Issue number8 I
StatePublished - 1981
Externally publishedYes

Fingerprint

Antipyrine
Cytochrome P-450 Enzyme System
Pharmaceutical Preparations
Genes

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Genetic variation in rates of antipyrine metabolite formation : A study in uninduced twins. / Penno, M. B.; Dvorchik, B. H.; Vesell, E. S.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 78, No. 8 I, 1981, p. 5193-5196.

Research output: Contribution to journalArticle

@article{9a9da9e847d04fc8a03682fae54a8b15,
title = "Genetic variation in rates of antipyrine metabolite formation: A study in uninduced twins",
abstract = "Adult, male, unmedicated twins received anti-pyrine orally under carefully controlled environmental conditions. Relative contributions of genetic and environmental factors to 2-fold interindividual variations in rate constants for formation of the three main antipyrine metabolites were compared. Heritabilities for rate constants for formation of 4-hydroxyantipyrine, N-demethylantipyrine, and 3-hydroxymethylantipyrine were 0.88, 0.85, and 0.70, respectively. These results suggest that each molecular form of cytochrome P-450 that converts antipyrine to a different metabolite exhibits genetically controlled interindividual variations in activity. Unrelated adult male subjects whose environments were also carefully controlled exhibited highly reproducible rate constants for formation of antipyrine metabolites. Because the rate constant for metabolite formation sensitively detects certain variations in the gene product, it should be used in future pharmacogenetic studies on rates of production of multiple metabolites from a single parent drug.",
author = "Penno, {M. B.} and Dvorchik, {B. H.} and Vesell, {E. S.}",
year = "1981",
language = "English (US)",
volume = "78",
pages = "5193--5196",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8 I",

}

TY - JOUR

T1 - Genetic variation in rates of antipyrine metabolite formation

T2 - A study in uninduced twins

AU - Penno, M. B.

AU - Dvorchik, B. H.

AU - Vesell, E. S.

PY - 1981

Y1 - 1981

N2 - Adult, male, unmedicated twins received anti-pyrine orally under carefully controlled environmental conditions. Relative contributions of genetic and environmental factors to 2-fold interindividual variations in rate constants for formation of the three main antipyrine metabolites were compared. Heritabilities for rate constants for formation of 4-hydroxyantipyrine, N-demethylantipyrine, and 3-hydroxymethylantipyrine were 0.88, 0.85, and 0.70, respectively. These results suggest that each molecular form of cytochrome P-450 that converts antipyrine to a different metabolite exhibits genetically controlled interindividual variations in activity. Unrelated adult male subjects whose environments were also carefully controlled exhibited highly reproducible rate constants for formation of antipyrine metabolites. Because the rate constant for metabolite formation sensitively detects certain variations in the gene product, it should be used in future pharmacogenetic studies on rates of production of multiple metabolites from a single parent drug.

AB - Adult, male, unmedicated twins received anti-pyrine orally under carefully controlled environmental conditions. Relative contributions of genetic and environmental factors to 2-fold interindividual variations in rate constants for formation of the three main antipyrine metabolites were compared. Heritabilities for rate constants for formation of 4-hydroxyantipyrine, N-demethylantipyrine, and 3-hydroxymethylantipyrine were 0.88, 0.85, and 0.70, respectively. These results suggest that each molecular form of cytochrome P-450 that converts antipyrine to a different metabolite exhibits genetically controlled interindividual variations in activity. Unrelated adult male subjects whose environments were also carefully controlled exhibited highly reproducible rate constants for formation of antipyrine metabolites. Because the rate constant for metabolite formation sensitively detects certain variations in the gene product, it should be used in future pharmacogenetic studies on rates of production of multiple metabolites from a single parent drug.

UR - http://www.scopus.com/inward/record.url?scp=0019805545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019805545&partnerID=8YFLogxK

M3 - Article

C2 - 6946467

AN - SCOPUS:0019805545

VL - 78

SP - 5193

EP - 5196

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8 I

ER -